|
|
|
|
LEADER |
01440cam a2200397 4500 |
001 |
PPN115993118 |
005 |
20210415055600.0 |
010 |
|
|
|a 978-0-8247-2945-5
|b rel.
|
010 |
|
|
|a 0-8247-2945-5
|
020 |
|
|
|a US
|b 2007008964
|
100 |
|
|
|a 20070705d2007 k y0frey0103 ba
|
101 |
0 |
|
|a eng
|
102 |
|
|
|a US
|
105 |
|
|
|a y a 001yy
|
106 |
|
|
|a r
|
200 |
0 |
|
|a Oral lipid-based formulations
|b Texte imprimé
|e enhancing the bioavailability of poorly water-soluable drugs
|f [edited by] David J. Hauss
|
210 |
|
|
|a New York, NY
|c Informa Healthcare USA
|d cop. 2007
|
215 |
|
|
|a 1 vol. (XII-339 p.)
|d ill.
|d 24 cm
|
225 |
2 |
|
|a Drugs and the pharmaceutical sciences
|v 170
|
320 |
|
|
|a Notes bibliogr. Index.
|
410 |
|
| |
|0 039504492
|t Drugs and the pharmaceutical sciences
|x 0360-2583
|v 170
|
606 |
|
|
|3 PPN027658449
|a Lipides
|3 PPN027790118
|x Emploi en thérapeutique
|2 rameau
|
606 |
|
|
|3 PPN032318073
|a Médicaments
|x Solubilité
|2 rameau
|
606 |
|
|
|3 PPN027654575
|a Solutions (pharmacie)
|2 rameau
|
606 |
|
|
|3 PPN027618579
|a Formes pharmaceutiques
|2 rameau
|
676 |
|
|
|a 615/.1
|v 22
|
680 |
|
|
|a RS201.E87
|b O73 2007
|
686 |
|
|
|a W1
|b DR893B v.170 2007
|2 usnlm
|
686 |
|
|
|a QV 38
|b O635 2007
|2 usnlm
|
702 |
|
1 |
|3 PPN115994270
|a Hauss
|b David J.
|4 340
|
801 |
|
3 |
|a FR
|b Abes
|c 20071220
|g AFNOR
|
801 |
|
0 |
|b DNLM/DLC
|g AACR2
|
801 |
|
1 |
|b DLC
|g AACR2
|
930 |
|
|
|5 441092101:323710395
|b 441092101
|a QV 38 ORA
|j u
|
979 |
|
|
|a SAN
|
998 |
|
|
|a 510821
|